Indications and uses
Unna Boots with Zinc Oxide and Calamine helps protect skin while offering compression and support.
Unna Boots with Zinc Oxide and Calamine helps protect skin while offering compression and support.
Apply as needed Cleanse the leg and moisturize the skin, if necessary If a wound is present, apply an appropriate wound dressing for moist wound healing Position the foot and ankle at a 90° or right angle to the leg (dorsiflexed) Begin wrapping the medicated bandage without tension at the base of the toes. Wrap the leg with a light tension, overlapping each layer by approximately 50%, in a spiral fashion Wrap up t...
Drug Facts
(in each gram)
Zinc Oxide 3%
Calamine 3%
Skin Protectant
Skin Protectant
For external use only.
Castor Oil, Glycerin, Methylparaben, Propylparaben.
Call 1-800-777-4908
NDC 68599-6112-2
McKESSON
Unna Boots
3"
WITH ZINC OXIDE & CALAMINE | NON-STERILE
3" x 10 yds
(7.6 cm x 9.1 m)
1
PER BOX
12
BOXES PER CASE
DO NOT REUSE
Keep away from sunlight. Store in a dry, ventilated area. Do not
store above 77°F (25°C). Not made with natural rubber latex.
Questions? Call 1-800-777-4908
Satisfaction Guaranteed
MFR # 2068
Distributed By
McKesson Medical-Surgical Inc.
Richmond, VA 23228
Rev. 01 04/14
Made in Germany
LOT
EXP

NDC 68599-6114-2
McKESSON
Unna Boots
4"
WITH ZINC OXIDE & CALAMINE | NON-STERILE
4" x 10 yds
(10.2 cm x 9.1 m)
1
PER BOX
12
BOXES PER CASE
DO NOT REUSE
Keep away from sunlight. Store in a dry, ventilated area. Do not
store above 77°F (25°C). Not made with natural rubber latex.
Questions? Call 1-800-777-4908
Satisfaction Guaranteed
MFR # 2069
Distributed By
McKesson Medical-Surgical Inc.
Richmond, VA 23228
Rev. 01 04/14
Made in Germany
LOT
EXP

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68599-6112-2 | 2022-07-15 | C162847 | 48780-1 | 9d75b9d0-9b68-f424-e053-dadaa90a57ce | 85026892-679c-4bdc-9099-8f32ea7456e7 |
| 68599-6114-2 | 2022-07-15 | C162847 | 48780-1 | 9d75b9d0-9b68-f424-e053-dadaa90a57ce | 85026892-679c-4bdc-9099-8f32ea7456e7 |
| 68599-6112-2 | 2020-03-28 | C162847 | 48780-1 | 9d75b9d0-9b68-f424-e053-dadaa90a57ce | 85026892-679c-4bdc-9099-8f32ea7456e7 |
| 68599-6114-2 | 2020-03-28 | C162847 | 48780-1 | 9d75b9d0-9b68-f424-e053-dadaa90a57ce | 85026892-679c-4bdc-9099-8f32ea7456e7 |
| 68599-6112-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9b68-f424-e053-dadaa90a57ce | 85026892-679c-4bdc-9099-8f32ea7456e7 |
| 68599-6114-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9b68-f424-e053-dadaa90a57ce | 85026892-679c-4bdc-9099-8f32ea7456e7 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Ferric Oxide Red | ACTIVE INGREDIENT | 1K09F3G675 | 2 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 2 | |
| Ferric Oxide Red | ACTIVE MOIETY | 1K09F3G675 | 2 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 2 | |
| Castor Oil | INACTIVE INGREDIENT | D5340Y2I9G | 2 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| Methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 2 | |
| Propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68599-6112 | 68599-6112-3, 68599-6112-2 |
| 68599-6114 | 68599-6114-3, 68599-6114-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CASTOR OIL | D5340Y2I9G | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| ZINC OXIDE | SOI2LOH54Z | ACTIB |
| FERRIC OXIDE RED | 1K09F3G675 | ACTIB |
| CASTOR OIL | D5340Y2I9G | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| ZINC OXIDE | SOI2LOH54Z | ACTIB |
| FERRIC OXIDE RED | 1K09F3G675 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | ELIXIR / ORAL | 800 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SUSPENSION / INTRAMUSCULAR | 0.02 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / RESPIRATORY (INHALATION) | 0.03 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SPRAY / TOPICAL | 0.8 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / ORAL | 100 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRALESIONAL | 0.15 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SHAMPOO / TOPICAL | 0.15 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / SOFT TISSUE | 0.15 %w/v | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE, EXTENDED RELEASE / ORAL | 0.22 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SYSTEM / TOPICAL | 42 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / INTRAVENOUS | 0.13 %w/v | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.02 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / SOFT TISSUE | 0.02 %w/v | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | POWDER / ORAL | NA | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE / ORAL | 1 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | TABLET, EXTENDED RELEASE / ORAL | 0.17 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | EMULSION / OPHTHALMIC | 32 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / AURICULAR (OTIC) | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | CAPSULE / ORAL | 7 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | TABLET, COATED / ORAL | 0.8 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SUSPENSION / ORAL | 75 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SUPPOSITORY / VAGINAL | NA | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | CAPSULE, EXTENDED RELEASE / ORAL | 2 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | EMULSION / TOPICAL | 0.06 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | OINTMENT / OPHTHALMIC | 0.05 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | FILM, SOLUBLE / BUCCAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / ORAL | 346 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION/ DROPS / OPHTHALMIC | 0.01 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | FILM / BUCCAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | OINTMENT / TOPICAL | 14.9 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAMUSCULAR | 6 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | FILM / BUCCAL | 0.22 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SHAMPOO / TOPICAL | 0.03 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION/ DROPS / OPHTHALMIC | 0.01 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | DROPS / NASAL | 26 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | GEL / NASAL | 429 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / SUBCUTANEOUS | 0.02 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / SUBCUTANEOUS | 0.16 %w/v | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION, EXTENDED RELEASE / ORAL | 4 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | TABLET / ORAL | 0.2 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION, CONCENTRATE / ORAL | 1 mg/1ml | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | ENEMA / RECTAL | 0.18 %w/v | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SHAMPOO, SUSPENSION / TOPICAL | 0.15 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2472aadf-e59b-8d8e-e063-6294a90adde5 | 85026892-679c-4bdc-9099-8f32ea7456e7 | 2024-10-14 | Warnings | 85026892-679c-4bdc-9099-8f32ea7456e7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.